{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:52:39Z","timestamp":1788785559400,"version":"build-2803163510"},"reference-count":133,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2004,6,16]],"date-time":"2004-06-16T00:00:00Z","timestamp":1087344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Endocrinology"],"published-print":{"date-parts":[[2004,7]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold><jats:sc>objective\u2002<\/jats:sc><\/jats:bold> To investigate to what extent thyroid remnant ablation and withdrawal from thyroxine are required to achieve sufficient accuracy of serum thyroglobulin (Tg) measurements as an indicator of tumour recurrence in the follow\u2010up of patients with differentiated thyroid carcinoma.<\/jats:p><jats:p><jats:bold><jats:sc>design and methods\u2002<\/jats:sc><\/jats:bold> We conducted a meta\u2010analysis of the literature from 1975 to 2003 on serum Tg measurements in the follow\u2010up of differentiated thyroid carcinoma. In a computer\u2010based search, we initially found 915 articles that were finally narrowed down to 120. These 120 papers were subjected to strict in\/and exclusion criteria, leaving 46 articles (totalling 9094 patients). Data from these articles were extracted in a structured fashion and were grouped according to initial therapy, TSH status, Tg assay method and definition of a \u2018gold standard\u2019. Original 2\u00a0\u00d7\u00a02 tables were pooled by summary receiver operating characteristic curve analysis (sROCa), best estimates of sensitivity and specificity being obtained by the combination of sROCa and Mantel\u2013Haenszel odds ratios.<\/jats:p><jats:p><jats:bold><jats:sc>results\u2002<\/jats:sc><\/jats:bold> Despite considerable differences between series in laboratory and clinical methodology, we consistently found higher specificity for Tg measurements after thyroid remnant ablation than after surgery alone. Highest pooled sensitivity 0\u00b7961\u00a0\u00b1\u00a00\u00b7013 (SE) was found for immunometric assay (IMA) after thyroid remnant ablation and thyroid hormone withdrawal, at a specificity of 0\u00b7947\u00a0\u00b1\u00a00\u00b7007. Pooled sensitivity decreased significantly if ablated patients were tested while on thyroid hormone (0\u00b7778\u00a0\u00b1\u00a00\u00b7023, at a specificity of 0\u00b7977\u00a0\u00b1\u00a00\u00b7005). Significantly decreased pooled specificity was found in patients who did not undergo remnant ablation (sensitivity 0\u00b7972\u00a0\u00b1\u00a00\u00b7023, at a specificity of 0\u00b7759\u00a0\u00b1\u00a00\u00b7028). If recombinant human TSH (rhTSH) stimulation was used as a substitute for thyroxine withdrawal, sensitivity remained high (0\u00b7925\u00a0\u00b1\u00a00\u00b7018) while specificity decreased to 0\u00b7880\u00a0\u00b1\u00a00\u00b7013. In all analyses, specificity of Tg would decrease when unspecified activity in the thyroid region at scintigraphy was considered benign, whereas sensitivity decreased when such activity was considered malignant.<\/jats:p><jats:p><jats:bold><jats:sc>conclusion\u2002<\/jats:sc><\/jats:bold> This study confirms that the best accuracy of Tg\u2010guided follow\u2010up in patients treated for differentiated thyroid carcinoma is obtained if treatment includes remnant ablation, and Tg testing is performed while off thyroxine.<\/jats:p>","DOI":"10.1111\/j.1365-2265.2004.02060.x","type":"journal-article","created":{"date-parts":[[2004,6,22]],"date-time":"2004-06-22T11:27:09Z","timestamp":1087903629000},"page":"61-74","source":"Crossref","is-referenced-by-count":148,"title":["Diagnostic value of serum thyroglobulin measurements in the follow\u2010up of differentiated thyroid carcinoma, a structured meta\u2010analysis"],"prefix":"10.1111","volume":"61","author":[{"given":"C. F. A.","family":"Eustatia\u2010Rutten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. W. A.","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. A.","family":"Romijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. P. M.","family":"Van Der Kleij\u2010Corssmit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. M.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. P.","family":"Stokkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kievit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,6,16]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.150.2.437"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1053\/beem.2000.0106"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003072-200006000-00011"},{"key":"e_1_2_5_5_1","first-page":"1010","article-title":"FDG PET of recurrent or metastatic 131I\u2010negative papillary thyroid carcinoma","volume":"41","author":"Alnafisi N.S.","year":"2000","journal-title":"Journal of Nuclear Medicine"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s004230050109"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03345495"},{"key":"e_1_2_5_8_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1995.5.25"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006231-200109000-00012"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1089\/105072502760258686"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1994.4.239"},{"key":"e_1_2_5_12_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021365"},{"key":"e_1_2_5_13_1","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1055\/s-0038-1623805","article-title":"Serum thyroglobulin determinations in patients with differentiated thyroid carcinoma","volume":"22","author":"Bednar J.","year":"1983","journal-title":"Nuklearmedizin"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/00022744-200009000-00004"},{"key":"e_1_2_5_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1991.tb00937.x"},{"key":"e_1_2_5_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1987.tb00846.x"},{"key":"e_1_2_5_17_1","first-page":"673","article-title":"Serum thyroglobulin, a monitor of differentiated thyroid carcinoma in patients receiving thyroid hormone suppression therapy: concise communication","volume":"25","author":"Blahd W.H.","year":"1984","journal-title":"Journal of Nuclear Medicine"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1410460"},{"key":"e_1_2_5_19_1","first-page":"635","article-title":"Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. The Standards for Reporting of Diagnostic Accuracy Group","volume":"44","author":"Bossuyt P.M.","year":"2003","journal-title":"Croatian Medical Journal"},{"key":"e_1_2_5_20_1","first-page":"1536","article-title":"Technetium\u201099m\u2010furifosmin in the follow\u2010up of differentiated thyroid carcinoma","volume":"39","author":"Brandt\u2010Mainz K.","year":"1998","journal-title":"Journal of Nuclear Medicine"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01566010"},{"key":"e_1_2_5_22_1","unstructured":"British Thyroid Association(2002)Guidelines for the Management of Differentiated Thyroid Cancer in Adults.http:\/\/www.british\u2010thyroid\u2010association.org\/guidelines.htm."},{"key":"e_1_2_5_23_1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1210\/jcem.85.1.6310","article-title":"Is diagnostic iodine\u2010131 scanning useful after total thyroid ablation for differentiated thyroid cancer?","volume":"85","author":"Cailleux A.F.","year":"2000","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"e_1_2_5_24_1","first-page":"686","article-title":"Total\u2010body scintigraphy with thallium\u2010201 and iodine\u2010131 in the follow\u2010up of differentiated thyroid cancer","volume":"38","author":"Carril J.M.","year":"1997","journal-title":"Journal of Nuclear Medicine"},{"key":"e_1_2_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(80)90011-X"},{"key":"e_1_2_5_26_1","first-page":"986","article-title":"Value of FDG PET in papillary thyroid carcinoma with negative 131I whole\u2010body scan","volume":"40","author":"Chung J.K.","year":"1999","journal-title":"Journal of Nuclear Medicine"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00801623"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19930601)71:11<3767::AID-CNCR2820711146>3.0.CO;2-W"},{"key":"e_1_2_5_29_1","first-page":"1470","article-title":"Serum thyroglobulin concentrations and 131I whole\u2010body scan results in patients with differentiated thyroid carcinoma after administration of recombinant human thyroid\u2010stimulating hormone","volume":"42","author":"David A.","year":"2001","journal-title":"Journal of Nuclear Medicine"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-71-2-414"},{"key":"e_1_2_5_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002590050158"},{"key":"e_1_2_5_32_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1997.7.613"},{"key":"e_1_2_5_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009-8981(80)90091-1"},{"key":"e_1_2_5_34_1","first-page":"235","article-title":"Critical evaluation of serum thyroglobulin levels and I\u2010131 scans in post\u2010therapy patients with differentiated thyroid carcinoma: concise communication","volume":"23","author":"Echenique R.L.","year":"1982","journal-title":"Journal of Nuclear Medicine"},{"key":"e_1_2_5_35_1","doi-asserted-by":"publisher","DOI":"10.1259\/0007-1285-61-724-317"},{"key":"e_1_2_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(91)70216-O"},{"key":"e_1_2_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(85)90146-1"},{"key":"e_1_2_5_38_1","first-page":"1468","article-title":"Fluorine\u201018\u2010FDG and iodine\u2010131\u2010iodide uptake in thyroid cancer","volume":"37","author":"Feine U.","year":"1996","journal-title":"Journal of Nuclear Medicine"},{"key":"e_1_2_5_39_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03350129"},{"key":"e_1_2_5_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19830615)51:12<2240::AID-CNCR2820511215>3.0.CO;2-#"},{"key":"e_1_2_5_41_1","first-page":"1542","article-title":"Role of initial iodine\u2010131 whole\u2010body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases","volume":"39","author":"Filesi M.","year":"1998","journal-title":"Journal of Nuclear Medicine"},{"key":"e_1_2_5_42_1","first-page":"446","article-title":"Thyroglobulin determination, neck ultrasonography and iodine\u2010131 whole\u2010body scintigraphy in differentiated thyroid carcinoma","volume":"37","author":"Franceschi M.","year":"1996","journal-title":"Journal of Nuclear Medicine"},{"key":"e_1_2_5_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11031"},{"key":"e_1_2_5_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006231-199701000-00003"},{"key":"e_1_2_5_45_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-200112000-00012"},{"key":"e_1_2_5_46_1","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1210\/jcem.87.7.8653","article-title":"Highly sensitive serum thyroglobulin and circulating thyroglobulin mRNA evaluations in the management of patients with differentiated thyroid cancer in apparent remission","volume":"87","author":"Fugazzola L.","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"e_1_2_5_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445-5994.1982.tb03805.x"},{"key":"e_1_2_5_48_1","first-page":"870","article-title":"Thyroglobulin and low\u2010dose iodine\u2010131 and technetium\u201099m\u2010tetrofosmin whole\u2010body scintigraphy in differentiated thyroid carcinoma","volume":"39","author":"Gallowitsch H.J.","year":"1998","journal-title":"Journal of Nuclear Medicine"},{"key":"e_1_2_5_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002590050270"},{"key":"e_1_2_5_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-002-0781-x"},{"key":"e_1_2_5_51_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1490293"},{"key":"e_1_2_5_52_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19970201)79:3<564::AID-CNCR20>3.0.CO;2-0"},{"key":"e_1_2_5_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00253296"},{"key":"e_1_2_5_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00254469"},{"key":"e_1_2_5_55_1","doi-asserted-by":"publisher","DOI":"10.1089\/105072501750362718"},{"key":"e_1_2_5_56_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19841015)54:8<1625::AID-CNCR2820540825>3.0.CO;2-0"},{"key":"e_1_2_5_57_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1997.7.327"},{"key":"e_1_2_5_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002590050493"},{"key":"e_1_2_5_59_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005537-200301000-00014"},{"key":"e_1_2_5_60_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00256492"},{"key":"e_1_2_5_61_1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.1800770329"},{"key":"e_1_2_5_62_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.84.11.3877"},{"key":"e_1_2_5_63_1","first-page":"1464","article-title":"Clinical impact of (18)F\u2010FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative 131I scanning results after therapy","volume":"42","author":"Helal B.O.","year":"2001","journal-title":"Journal of Nuclear Medicine"},{"key":"e_1_2_5_64_1","doi-asserted-by":"publisher","DOI":"10.1081\/ERC-120018672"},{"key":"e_1_2_5_65_1","first-page":"327","article-title":"A comparison of the effectiveness of 131I whole body scans and plasma Tg determinations in the diagnosis of metastatic differentiated carcinoma of the thyroid: a retrospective study","volume":"104","author":"Hufner M.","year":"1983","journal-title":"Acta Endocrinologica (Copenhagen)"},{"key":"e_1_2_5_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1"},{"key":"e_1_2_5_67_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006231-199806000-00006"},{"key":"e_1_2_5_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002590000443"},{"key":"e_1_2_5_69_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006231-200006000-00005"},{"key":"e_1_2_5_70_1","doi-asserted-by":"publisher","DOI":"10.1053\/nm.2000.4599"},{"key":"e_1_2_5_71_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199709253371304"},{"key":"e_1_2_5_72_1","first-page":"273","article-title":"Interference of specific autoantibodies in the assessment of serum thyroglobulin","volume":"37","author":"Ligabue A.","year":"1993","journal-title":"The Journal of Nuclear Biology and Medicine"},{"key":"e_1_2_5_73_1","first-page":"378","article-title":"Clinical presentations and predictive variables of thyroid microcarcinoma with distant metastasis","volume":"82","author":"Lin K.D.","year":"1997","journal-title":"International Surgery"},{"key":"e_1_2_5_74_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002590050271"},{"key":"e_1_2_5_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0347(200102)23:2<140::AID-HED1009>3.0.CO;2-H"},{"key":"e_1_2_5_76_1","first-page":"141","article-title":"Thyroglobulin radioimmunoassay and 131I scintigraphy in patients with differentiated thyroid carcinoma","volume":"154","author":"Lindegaard M.W.","year":"1988","journal-title":"Acta Chirurgica Scandinavica"},{"key":"e_1_2_5_77_1","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X9301300408"},{"key":"e_1_2_5_78_1","first-page":"1487","article-title":"Thallium\u2010201 and iodine\u2010131 scintigraphy in differentiated thyroid carcinoma","volume":"37","author":"Lorberboym M.","year":"1996","journal-title":"Journal of Nuclear Medicine"},{"key":"e_1_2_5_79_1","first-page":"257","article-title":"Serum thyroglobulin and iodine\u2010131 whole\u2010body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma","volume":"35","author":"Lubin E.","year":"1994","journal-title":"Journal of Nuclear Medicine"},{"key":"e_1_2_5_80_1","first-page":"201","article-title":"Endogenously labeled thyroid hormones (131I\u2010T3\/T4) in sera of patients with differentiated thyroid carcinoma","volume":"6","author":"Lukinac L.","year":"1996","journal-title":"Thyroid"},{"key":"e_1_2_5_81_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.4.7407"},{"key":"e_1_2_5_82_1","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.87.4.8338"},{"key":"e_1_2_5_83_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021702"},{"key":"e_1_2_5_84_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.78.1.188"},{"key":"e_1_2_5_85_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2559.1999.00792.x"},{"key":"e_1_2_5_86_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1999.9.933"},{"key":"e_1_2_5_87_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780121403"},{"key":"e_1_2_5_88_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19880301)61:5<976::AID-CNCR2820610520>3.0.CO;2-U"},{"key":"e_1_2_5_89_1","first-page":"631","article-title":"99mTc\u2010sestamibi and 131I whole\u2010body scintigraphy and initial serum thyroglobulin in the management of differentiated thyroid carcinoma","volume":"41","author":"Ng D.C.","year":"2000","journal-title":"Journal of Nuclear Medicine"},{"key":"e_1_2_5_90_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6185.298"},{"key":"e_1_2_5_91_1","first-page":"643","article-title":"Follow\u2010up regimen of differentiated thyroid carcinoma in thyroidectomized patients after thyroid hormone withdrawal","volume":"41","author":"Oyen W.J.","year":"2000","journal-title":"Journal of Nuclear Medicine"},{"key":"e_1_2_5_92_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1980.tb01030.x"},{"key":"e_1_2_5_93_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1985.tb01098.x"},{"key":"e_1_2_5_94_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.12.5686"},{"key":"e_1_2_5_95_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021925"},{"key":"e_1_2_5_96_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2003.01744.x"},{"key":"e_1_2_5_97_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.5.1488"},{"key":"e_1_2_5_98_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19850401)55:7<1525::AID-CNCR2820550719>3.0.CO;2-S"},{"key":"e_1_2_5_99_1","first-page":"441","article-title":"Thallium\u2010201 scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum thyroglobulin determinations","volume":"32","author":"Ramanna L.","year":"1991","journal-title":"Journal of Nuclear Medicine"},{"key":"e_1_2_5_100_1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1210\/jcem.86.2.7189","article-title":"Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma","volume":"86","author":"Robbins R.J.","year":"2001","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"e_1_2_5_101_1","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1210\/jcem.87.7.8702","article-title":"Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma?","volume":"87","author":"Robbins R.J.","year":"2002","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"key":"e_1_2_5_102_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00879658"},{"key":"e_1_2_5_103_1","first-page":"1766","article-title":"Can iodine\u2010131 whole\u2010body scan be replaced by thyroglobulin measurement in the post\u2010surgical follow\u2010up of differentiated thyroid carcinoma?","volume":"31","author":"Ronga G.","year":"1990","journal-title":"Journal of Nuclear Medicine"},{"key":"e_1_2_5_104_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002590050477"},{"key":"e_1_2_5_105_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03349612"},{"key":"e_1_2_5_106_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002590050527"},{"key":"e_1_2_5_107_1","first-page":"395","article-title":"Thyroglobulin level as a predictive factor of tumoral recurrence in differentiated thyroid cancer","volume":"32","author":"Ruiz\u2010Garcia J.","year":"1991","journal-title":"Journal of Nuclear Medicine"},{"key":"e_1_2_5_108_1","doi-asserted-by":"publisher","DOI":"10.1080\/110241598750005543"},{"key":"e_1_2_5_109_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.75.3.714"},{"key":"e_1_2_5_110_1","doi-asserted-by":"publisher","DOI":"10.1089\/105072501750362754"},{"key":"e_1_2_5_111_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199801293380506"},{"key":"e_1_2_5_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/0277-5379(88)90278-7"},{"key":"e_1_2_5_113_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02262724"},{"key":"e_1_2_5_114_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1997.7.273"},{"key":"e_1_2_5_115_1","first-page":"1434","article-title":"Comparison of 99mTc\u2010methoxyisobutyl isonitrile and 201Tl scintigraphy for detection of residual thyroid cancer after 131I ablative therapy","volume":"40","author":"Seabold J.E.","year":"1999","journal-title":"Journal of Nuclear Medicine"},{"key":"e_1_2_5_116_1","first-page":"222","article-title":"Serum thyroglobulin differentiated thyroid carcinoma: histological and metastatic classification","volume":"98","author":"Shah D.H.","year":"1981","journal-title":"Acta Endocrinologica (Copenhagen)"},{"key":"e_1_2_5_117_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1979.tb03029.x"},{"key":"e_1_2_5_118_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2001.01376.x"},{"key":"e_1_2_5_119_1","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1001\/archinte.1996.00440180017002","article-title":"Treatment guidelines for patients with thyroid nodules and well\u2010differentiated thyroid cancer. American Thyroid Association","volume":"156","author":"Singer P.A.","year":"1996","journal-title":"Archives of Internal Medicine"},{"key":"e_1_2_5_120_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2000.10.165"},{"key":"e_1_2_5_121_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006231-199305000-00004"},{"key":"e_1_2_5_122_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/42.1.164"},{"key":"e_1_2_5_123_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.4.1121"},{"key":"e_1_2_5_124_1","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1001\/archinte.1995.00430180108012","article-title":"Perioperative mortality of elective abdominal aortic aneurysm surgery. A clinical prediction rule based on literature and individual patient data","volume":"155","author":"Steyerberg E.W.","year":"1995","journal-title":"Archives of Internal Medicine"},{"key":"e_1_2_5_125_1","first-page":"215","article-title":"Value of the estimation of thyroglobulin levels in the surveillance of treated differentiated thyroid carcinoma","volume":"22","author":"Sulman C.","year":"1984","journal-title":"Journal of Clinical Chemistry and Clinical Biochemistry"},{"key":"e_1_2_5_126_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-129-8-199810150-00007"},{"key":"e_1_2_5_127_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00171015"},{"key":"e_1_2_5_128_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1480589"},{"key":"e_1_2_5_129_1","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1480019"},{"key":"e_1_2_5_130_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19850215)55:4<794::AID-CNCR2820550418>3.0.CO;2-Z"},{"key":"e_1_2_5_131_1","first-page":"487","article-title":"How to deal with undetectable and low measurable serum thyroglobulin levels in the follow\u2010up of patients with differentiated thyroid carcinoma?","volume":"110","author":"Valimaki M.","year":"1985","journal-title":"Acta Endocrinologica (Copenhagen)"},{"key":"e_1_2_5_132_1","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1999.9.583"},{"key":"e_1_2_5_133_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0300-0664.2001.01425.x"},{"key":"e_1_2_5_134_1","doi-asserted-by":"publisher","DOI":"10.1089\/105072502320288438"}],"container-title":["Clinical Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2265.2004.02060.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2265.2004.02060.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T18:54:08Z","timestamp":1697223248000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2265.2004.02060.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,16]]},"references-count":133,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["10.1111\/j.1365-2265.2004.02060.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2265.2004.02060.x","archive":["Portico"],"relation":{},"ISSN":["0300-0664","1365-2265"],"issn-type":[{"value":"0300-0664","type":"print"},{"value":"1365-2265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6,16]]}}}